Screen Shot 2020-11-08 at 9-29-35 PM

Developing Your COVID-19 Strategy

When the healthcare world changes abruptly, your strategy needs to change too. Our experts, in combination with our experiences managing laboratories dealing with COVID-19 and industry experience, have created a guide to help you understand the considerations you should be making related to your COVID-19 strategy.

Download our guide by clicking this link.

Stay tuned for insights and strategies

As our team assesses the impact of COVID-19 on laboratory operations, we’ll be publishing updates. Volume, TAT, Staffing, Equipment, and more will require a complete rethink to ensure stable operations through this uncertain time.

For all strategic options, NMG will take a tactical approach and review multiple potentially affected factors:

  • Future volumes
  • Current and future locations within the system network
  • Integration and consolidation opportunities
  • Equipment standardization opportunities
  • Employee engagement
  • Standard workflow and process improvement opportunities
  • Partnership opportunities
  • Health care reform
  • Regulatory requirements
  • Reimbursement changes (PAMA)
  • Information Technology requirements
  • Capital demands

Get more information

What people say

NMG developed a staffing plan for reduced volumes using NMG’s Labscore database and industry benchmarking. Working with lab management and finance a transition staffing plan was developed which required a 30% reduction in FTEs due to a 40% drop in volumes.

Group-6

NMG developed a staffing plan for reduced volumes using NMG’s Labscore database and industry benchmarking. Working with lab management and finance a transition staffing plan was developed which required a 30% reduction in FTEs due to a 40% drop in volumes.

Group-6